Drug Manufacturing License in Panipat, Haryana
Drug manufacturing license in India: Form 25 & 28, GMP and Schedule M compliance, loan and third party manufacturing. Free consultation.
- Businesses operating or planning to open in Panipat
- Entities needing fast-track regulatory approval without delay
- First-time applicants requiring complete documentation guidance
Connect with our senior regulatory experts in 15 mins.
Overview & Local Scope
Fast-Track Drug Manufacturing License in India in Panipat
Drug manufacturing license in India: Form 25 & 28, GMP and Schedule M compliance, loan and third party manufacturing. Free consultation.
Need help with your application in Panipat?
Our local experts are ready to guide you through the process.
Businesses operating or planning to open in Panipat
Entities needing fast-track regulatory approval without delay
First-time applicants requiring complete documentation guidance
Your Drug Manufacturing License in Panipat, Haryana, Built Around Revised Schedule M
A drug manufacturing license is the permission granted under the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945 to manufacture medicines for sale, whether in your own plant or, under a loan license, in another company's licensed facility. It is product-specific: the license lists every product you are allowed to make, and each new product must be added before production. In Panipat, Haryana, the license is granted by the State Drug Licensing Authority of your state after a document review and a detailed inspection of the plant.
Pharma manufacturing licensing changed sharply in the last two years. The revised Schedule M good manufacturing practices, notified in December 2023, have applied to every allopathic manufacturer since 1 January 2026, with risk-based inspections checking compliance. A new plant in Panipat, Haryana gets no transition period: it must meet revised Schedule M at its pre-licensing inspection. That makes the design and documentation stage, not the application form, the place where most approvals are won or lost.
Regovex Consulting is a drug license consultant that works with pharma manufacturing companies from the planning stage. We map your products to the right license forms, run a revised Schedule M gap analysis of your layout and systems, prepare the Site Master File, SOPs and validation plans, file the application, answer queries within 24–48 hours, and brief your team before the inspection. For brands without a plant, we set up third-party manufacturing or a loan license correctly from day one.
Manufacturing licenses are granted by the state where the plant is located, with CDSCO joining for vaccines, sera, large-volume parenterals, blood products and new drugs; revised Schedule M applies nationwide.
Who Needs a Drug Manufacturing License in Panipat, Haryana?
Every business that manufactures, processes, packs or repacks drugs for sale needs a manufacturing license. In Panipat, Haryana, that includes:
- Pharma manufacturing companies making tablets, capsules, liquids, ointments, creams, powders or injectables
- New plants in industrial areas, before the first commercial batch
- Existing manufacturers adding new products, new dosage forms or a new block
- Brand owners using a loan license to make products in another company's licensed plant
- Repackers who repack bulk drugs into smaller packs for sale
- Ayurvedic, Siddha and Unani manufacturers, who are licensed under a parallel set of rules
- Research-led companies making test, stability or trial batches before commercial approval
A brand that has its products made by a third-party manufacturer under the manufacturer's own license does not need a manufacturing license itself, but it does carry legal responsibility as the marketer and needs a wholesale drug license to hold and sell the stock. We explain both routes below.
Types of Drug Manufacturing License: Which Form Does Your Pharma Manufacturing Unit Need?
The form depends on two things: which schedule your drugs fall in, and whether you manufacture in your own plant or in someone else's. Most pharma manufacturing units in Panipat, Haryana need Form 25, Form 28 or both. The fees below are the central amounts under the Drugs Rules, 1945, as published by the Delhi Drugs Control Department.
| License | What it covers | Application form | License fee | Inspection fee |
|---|---|---|---|---|
| Form 25 | Drugs other than those in Schedules C, C(1) and X: tablets, capsules, oral liquids, ointments, creams, powders | Form 24 | ₹6,000 for up to 10 items per category, + ₹300 per additional item | ₹1,500 per inspection |
| Form 28 | Drugs in Schedules C and C(1), excluding X: injectables, sterile products, biologicals | Form 27 | ₹6,000 for up to 10 items, + ₹300 per additional item | ₹1,500 per inspection |
| Form 25-A | Loan license for drugs other than Schedules C, C(1) and X | Form 24-A | ₹6,000 for up to 10 items, + ₹300 per additional item | ₹1,500 per inspection |
| Form 28-A | Loan license for Schedule C and C(1) drugs | Form 27-A | ₹6,000 for up to 10 items, + ₹300 per additional item | ₹1,500 per inspection |
| Form 25-F | Schedule X drugs not in Schedules C and C(1) | Form 24-F | ₹6,000 for up to 10 items, + ₹300 per additional item | ₹1,500 per inspection |
| Form 28-B | Schedule C(1) drugs that are also in Schedule X | Form 27-B | ₹6,000 for up to 10 items, + ₹300 per additional item | ₹1,500 per inspection |
| Form 28-D | Large-volume parenterals, sera and vaccines (central approval) | Form 27-D | ₹6,000 for up to 10 items, + ₹300 per additional item | ₹1,500 per inspection |
| Form 25-B | Repacking of drugs other than Schedules C, C(1) and X | Form 24-B | ₹500 for up to 10 items, + ₹100 per additional item | ₹200 per inspection |
| Form 29 | Test license: small quantities for examination, test or analysis | Form 30 | ₹250 | — |
Blood banks and blood products follow their own forms and are outside the scope of this page. Fees can change; we confirm the payable amount on the Online National Drugs Licensing System (ONDLS) or your state's own portal before you pay. Source: Delhi Drugs Control Department.
Form 25 and Form 28: the core manufacturing licenses
A plant making oral solid dosage forms (tablets and capsules) and external preparations usually needs Form 25. A plant making injectables or other sterile products needs Form 28, and its clean rooms, water system and sterilisation processes face the strictest inspection. Many plants hold both, with separate blocks for each.
Ayurvedic, Siddha and Unani manufacturing (Form 25-D)
Ayurvedic, Siddha and Unani medicines are licensed under a separate part of the Drugs Rules, with Form 24-D as the application and Form 25-D as the license, granted by the state's AYUSH licensing authority. These units follow Schedule T good manufacturing practices, not Schedule M. Regovex files AYUSH manufacturing and loan licenses as well.
Test license (Form 29)
A test license lets you make small quantities of a drug for examination, testing or analysis, such as stability, validation or trial batches, before the commercial license is in place. Filing it early, in parallel with the main application, saves months on new product launches.
Product permission: every product must be listed
A manufacturing license is not a blank cheque. Each product, with its composition and strength, must be approved and listed on the license before you manufacture it. A product that counts as a new drug, or a fixed-dose combination not yet approved in India, first needs permission from CDSCO. Regovex checks your product list against these rules before filing, so the license covers everything you plan to make.
Who Approves a Drug Manufacturing License: State Licensing Authority or CDSCO?
For most pharma manufacturing, the license comes from the state. the State Drug Licensing Authority of your state grants Form 25, Form 28 and loan licenses for ordinary formulations after inspecting the plant. CDSCO, the central regulator, comes in at three points:
| Situation | Who decides | What it means for you |
|---|---|---|
| Ordinary formulations (tablets, capsules, liquids, ointments, most injectables) | State Licensing Authority | State inspection; CDSCO may join inspections under current risk-based programmes |
| Vaccines, sera, large-volume parenterals, blood products and some biologicals | State Licensing Authority grants, with approval of the Central License Approving Authority (the DCGI) | Joint inspection by state and CDSCO zonal officers; longer timeline |
| New drugs and new fixed-dose combinations | CDSCO permission first, then the state license | Product approval from CDSCO is a precondition for adding the product to your license |
For Uttar Pradesh, Delhi, Rajasthan and Uttarakhand, CDSCO's North Zone office at Ghaziabad handles the central side of joint inspections. A manufacturer who also wants to export usually needs a WHO-GMP or Certificate of Pharmaceutical Product (CoPP) inspection as well, which also involves CDSCO. As a drug regulatory consultant in India and CDSCO registration consultant, Regovex coordinates both the state and central sides of your file.
Revised Schedule M in 2026: What Every Manufacturer in Panipat, Haryana Must Meet
Revised Schedule M is the updated set of good manufacturing practices for allopathic drug manufacturers, notified by G.S.R. 922(E) on 28 December 2023 and aligned with WHO GMP. Large manufacturers (turnover above ₹250 crore) had to comply first. Small and medium manufacturers could seek an extension to 31 December 2025 by filing an upgrade plan in Form A. Reports in late December 2025 indicated no further general extension, and from 1 January 2026 the revised Schedule M applies to every manufacturer, with risk-based inspections checking compliance.
For a new plant in Panipat, Haryana, there is no transition period: the pre-licensing inspection is judged against revised Schedule M.
What changed in revised Schedule M
- Pharmaceutical Quality System (PQS): a documented, management-owned quality system covering the full product lifecycle
- Quality Risk Management: risk assessment built into processes, changes and deviations
- Product Quality Review: an annual review of every product's quality data and trends
- Validation and qualification: equipment, utilities, processes, cleaning and analytical methods must be qualified or validated
- Data integrity: controlled, traceable records, including computerised systems
- Change control, deviations and CAPA: formal systems to record, investigate and close every change and failure
- Supplier qualification: approved vendors for raw and packing materials, with audits where needed
- Stability studies: stability data to support every product's shelf life
- Stricter requirements for sterile products, including clean room classification and environmental monitoring
Schedule M gap analysis before you build or apply
The cheapest time to meet Schedule M is before construction. Changing a wall, a drain or an air-handling unit after inspection costs far more than getting the layout right on paper. Regovex reviews your plant layout, people and material flow, HVAC zoning, water system and documentation against revised Schedule M, gives you a prioritised gap list, and helps you close it before the inspection is booked. Existing units in Panipat, Haryana can use the same review to prepare for risk-based inspections.
GMP Guidelines for Pharma Manufacturing: Schedule M, cGMP and Schedule T
GMP guidelines are the rules on how medicines must be made, tested, stored and documented so that every batch is safe and consistent. In India, GMP in pharma is not optional advice: it is a legal condition of every manufacturing license India grants. Allopathic drug makers follow revised Schedule M of the Drugs Rules, 1945; Ayurvedic, Siddha and Unani makers follow Schedule T. A plant that does not meet the applicable GMP guidelines will not get a manufacturing license, and an existing licence can be suspended after a failed inspection.
What GMP in pharma covers
| GMP area | What inspectors in Panipat, Haryana expect |
|---|---|
| Premises | Layout with one-way flow of people and materials, separate areas for each stage, cleanable surfaces |
| Equipment | Qualified equipment with cleaning and calibration records |
| Utilities | Purified water system, HVAC with the right air classes, compressed air where used |
| People | Qualified, trained staff with records of training and hygiene |
| Documentation | Batch manufacturing records, SOPs and controlled documents, with data integrity |
| Quality control | A laboratory or approved testing for raw materials, in-process and finished products |
| Quality system | Change control, deviations, CAPA, complaints, recalls and annual product quality reviews |
cGMP pharma: what the "c" means
cGMP pharma means current good manufacturing practice: GMP applied to today's expectations, not the minimum written years ago. Revised Schedule M brought India's rules close to WHO GMP and the cGMP standards used by major regulators, with a Pharmaceutical Quality System, quality risk management, validation and data integrity at its core. Pharma manufacturing companies that export, or that supply buyers who audit to WHO GMP or other international standards, are judged against cGMP expectations as well as Schedule M.
Schedule T for Ayurvedic, Siddha and Unani manufacturing
Schedule T sets the GMP requirements for Ayurvedic, Siddha and Unani medicines: premises, raw material testing for identity and quality, manufacturing and quality control, and records. Units following Schedule T are licensed on Form 25-D by the state AYUSH licensing authority, not under Schedule M. A company making both allopathic and Ayurvedic products needs separate licences and separate areas meeting each schedule.
How GMP links to your manufacturing license
The manufacturing license is granted only after an inspection confirms the plant meets the GMP guidelines for its products. After grant, risk-based inspections check that GMP is kept up, and buyers, export markets and tenders often ask for a GMP certificate issued by the licensing authority. Regovex prepares your plant and documents for each of these: the pre-licensing inspection, routine inspections and GMP certificate applications.
Eligibility for a Drug Manufacturing License in Panipat, Haryana
A drug manufacturing license is granted to the plant, its people and its systems together. The licensing authority checks four things.
- A suitable site and building. An industrial plot or building legally usable for manufacturing, designed with separate areas for raw material storage, sampling, dispensing, production, packing, quarantine, finished goods and quality control, and with the people and material flow that revised Schedule M expects.
- Qualified technical staff. At least one competent person in charge of manufacture and a separate person in charge of testing, both full-time and with the qualifications and experience the rules require (see below).
- Equipment, utilities and a quality control laboratory. Equipment for each dosage form, a purified water system, HVAC suited to each area, and a QC laboratory able to test raw materials, in-process samples and finished products, or an approved testing arrangement where the rules allow it.
- A working quality system. Written SOPs, batch manufacturing records, validation and qualification documents, and a Pharmaceutical Quality System under revised Schedule M.
Technical staff qualifications
| Role | Typical qualification | Typical experience |
|---|---|---|
| In charge of manufacture | Degree in Pharmacy or Pharmaceutical Chemistry | At least 18 months in drug manufacture after graduation |
| In charge of manufacture (alternative) | Graduate in Science with Chemistry, or in Chemical Engineering, Chemical Technology or Medicine | Usually 3 years in drug manufacture |
| In charge of testing (QC head) | Degree in Pharmacy, Pharmaceutical Chemistry, or Science with Chemistry, or related disciplines | Experience in drug testing, as the rules and state practice require; must be a different person from the manufacturing head |
Requirements differ for sterile products, biologicals and Schedule X drugs, and states apply them with their own checklists. We verify each person's degree, experience certificates and approvals before they are named in the application, because a technical staff rejection stops the whole file.
Premises and plant requirements at a glance
- Separate, well-defined areas for each stage, with no cross-over of clean and dirty flows
- Finishes that are smooth, cleanable and dust-free in production areas
- HVAC with appropriate filtration, pressure differentials and, for sterile areas, classified clean rooms
- A purified water system (and water for injection for parenterals), qualified and monitored
- Dedicated or segregated facilities where the product's risk requires it
- Warehouse areas for quarantine, approved, rejected and returned materials
- A QC laboratory with instruments qualified for the tests you will run
Documents Required for a Drug Manufacturing License
The documents for a drug manufacturing license are heavier than for any sale license. A complete file in Panipat, Haryana usually includes:
Company and site documents
- Proof of constitution and list of directors or partners, with identity and address proofs
- Ownership deed or lease of the plant, and proof that the land is approved for industrial use
- Site plan, key plan and detailed layout drawings showing each area, people and material flow, HVAC zoning and drains
- Pollution control board consent to establish or operate, and other local approvals, where required
- Non-conviction affidavits of the owners
Technical and quality documents
- Site Master File describing the company, plant, equipment, utilities, quality system and personnel
- Product list with composition, strength, dosage form and category for each product
- Master formula records and manufacturing process outlines for each product
- List of equipment and instruments, with qualification status
- Water system and HVAC design and qualification documents
- SOP index, validation master plan and stability plan
- Technical staff qualification and experience certificates, appointment letters and consent letters
- For loan licenses, the agreement with the host manufacturer and the host's license copy
Regovex prepares or reviews each document against revised Schedule M and the current checklist of the State Drug Licensing Authority of your state, so the file and the plant tell the same story at inspection.
How to Get a Drug Manufacturing License in Panipat, Haryana: Step-by-Step
To get a drug manufacturing license in Panipat, Haryana, you design the plant to revised Schedule M, prepare the Site Master File and product documents, apply on the Online National Drugs Licensing System (ONDLS) or your state's own portal with the fee, pass the pre-licensing inspection, and receive the license listing your approved products. For ordinary formulations, approval usually takes three to six months from a complete application to a ready plant.
- Product and license planning. Fix the product list, dosage forms and categories, and confirm which forms you need (Form 25, 28, loan license, test license) and whether any product needs CDSCO permission first.
- Layout and Schedule M gap analysis. Review the plant design, flows, HVAC and water system before construction or modification.
- Technical staff. Appoint qualified persons in charge of manufacture and testing, and verify their documents.
- Documentation. Prepare the Site Master File, product documents, SOPs, validation plans and qualification records.
- Application. Register on the Online National Drugs Licensing System (ONDLS) or your state's own portal, file Form 24 or Form 27 (or the loan license forms), upload documents and pay the license and inspection fees.
- Scrutiny and queries. The licensing authority reviews the file. We reply to every query within 24–48 hours.
- Pre-licensing inspection. Drug Inspectors, joined by CDSCO officers where required, inspect the plant, equipment, QC laboratory, documents and staff.
- Compliance and grant. Any observations are closed with a compliance report. the State Drug Licensing Authority of your state then grants the license for the approved products.
What inspectors check in a pharma manufacturing plant
- The plant matches the approved layout, with correct flows and segregation
- HVAC performance, pressure differentials and, for sterile areas, clean room classification and monitoring
- Water system qualification and test results
- Equipment qualification and calibration
- QC laboratory capability, reference standards and instrument qualification
- Batch records, SOPs, training records and the quality system under revised Schedule M
- Technical staff present and able to explain their processes
Fees and timeline
| Item | Amount or time |
|---|---|
| License fee, Form 25 or Form 28 | ₹6,000 for up to 10 items per category |
| Each additional item | ₹300 |
| Inspection fee | ₹1,500 per inspection |
| Test license (Form 29) | ₹250 |
| Retention fee | Equal to the license fee, every 5 years |
| Typical approval time, ordinary formulations | 3–6 months from a complete application and ready plant |
| Products needing central approval | Longer, because of CDSCO joint inspection and approval |
Government fees are central amounts; some states add processing charges. A full plant project, from land to first commercial batch, usually takes much longer than the license itself, so we plan the license work in parallel with construction. Regovex's professional fee is quoted in writing after the free GMP readiness check, with government fees shown separately.
Common reasons manufacturing applications are delayed
- Layout flows or HVAC zoning that do not meet revised Schedule M
- Technical staff whose experience certificates do not meet the rules
- Products that need CDSCO permission listed as ordinary formulations
- A Site Master File that does not match the plant as built
- Water system or equipment not yet qualified at inspection
- Late or incomplete replies to inspection observations
Setting Up a New Pharma Manufacturing Plant in Panipat, Haryana: Approvals Beyond the Drug License
The drug manufacturing license is the last approval in a longer chain. A new plant in Panipat, Haryana usually needs the following, roughly in this order, and several of them are checked by the Drug Inspector during the pre-licensing inspection.
| Stage | Approval or registration | Why it matters for the drug license |
|---|---|---|
| Land | Industrial plot allotment or approved land use | The license is refused if the site cannot legally be used for manufacturing |
| Building | Building plan approval and completion certificate | Inspectors compare the layout drawings with the approved building |
| Environment | Consent to Establish, then Consent to Operate, from the State Pollution Control Board | Effluent, emissions and waste handling must be approved before production |
| Safety | Fire NOC from the fire department | Required for occupancy and checked by many licensing authorities |
| Labour | Factory registration and licence under the applicable labour law | Needed before employing workers in production |
| Utilities | Power connection, with backup for critical areas | HVAC, water systems and cold storage depend on stable power |
| Business | GST registration and Udyam registration for MSMEs | Needed for invoicing and for MSME benefits |
| Export (optional) | WHO-GMP or CoPP certification, through CDSCO | Many importing countries ask for it |
The most common delay is starting the drug license work only after construction ends. When the Site Master File, SOPs and validation plans are prepared in parallel with the building, the plant can be inspected soon after the equipment is installed. Regovex plans the license track alongside your construction schedule and coordinates with your architect, HVAC and water system vendors so that the plant is built to revised Schedule M the first time.
Third Party Manufacturing Pharma Companies in India: What Brand Owners Need Legally
Third-party manufacturing means a brand owner has its products made in another company's licensed plant and sells them under its own brand. It is how most new pharma brands in India start. Thousands of third party manufacturing pharma companies in India offer this service, but the legal set-up is the brand owner's responsibility as much as the manufacturer's.
Third party manufacturing pharma: contract manufacturing vs loan license
| Point | Contract manufacturing (manufacturer's license) | Loan license (brand owner's license) |
|---|---|---|
| Whose license lists the product | The manufacturer's Form 25 or 28 | The brand owner's Form 25-A or 28-A |
| Who applies | The manufacturer adds your product to its license | You apply, with the host plant's details and agreement |
| Brand owner also needs | Wholesale drug license to hold and sell stock | Wholesale drug license, plus loan license compliance |
| Control over manufacturing | Lower; the manufacturer runs the batch | Higher; your technical staff are involved |
| Typical fit | New brands, PCD and marketing companies | Established brands wanting more control |
In both routes, the Drugs Rules make the marketer responsible, along with the manufacturer, for the quality and regulatory compliance of the drugs it sells. The marketer's name appears on the label, and a quality failure can lead to action against both.
How to check third party manufacturing pharma companies before you sign
- License: ask for the manufacturer's current Form 25 or 28, and check that your exact products (composition and strength) are listed or can be added
- Schedule M status: ask for evidence that the plant meets revised Schedule M, such as the latest inspection report or compliance certificate
- Retention fee: confirm the license is current, with the latest retention fee receipt
- Dosage form capability: check that the plant has the block and equipment for your dosage form, especially for sterile products
- Testing: confirm the QC laboratory can test your products, and who keeps retention samples
- Quality agreement: sign a written technical or quality agreement setting out responsibilities for specifications, release, complaints, recalls and stability
- Track record: check for any recent not-of-standard-quality alerts linked to the plant
Regovex reviews third-party manufacturer licenses and agreements for brand owners and sets up your own wholesale and marketing compliance, so you launch with the right paperwork on both sides.
Pharma manufacturing companies offering contract services
For pharma manufacturing companies that make products for other brands, each brand's product must be properly added to your license, labels must carry the right manufacturer and marketer details, and your quality system must cover contract customers. Regovex handles additional product permissions and loan license hosting documentation for contract manufacturers.
Drug Manufacturing License Renewal, Retention Fee and Changes
A drug manufacturing license no longer expires in the old way. Since the Drugs Rules were amended in 2017, licenses remain valid unless suspended or cancelled, provided a retention fee, equal to the license fee, is paid before the end of every five-year period. A late payment within six months attracts a late fee of 2% per month; after that, the license is treated as cancelled.
Changes that need approval during the license period include:
- Adding new products, strengths or dosage forms
- Change of technical staff in charge of manufacture or testing
- Change of ownership, constitution or directors
- Major alterations to the plant layout, HVAC or water system
- Adding a new block or a new site, which needs its own license
Compliance After You Get Your Drug Manufacturing License
Inspections continue after the license is granted, and under the current risk-based approach, plants with weak systems are inspected more often. The duties that matter most are:
- Batch release: every batch tested and released by the QC head before sale
- Records: batch manufacturing and packing records, kept and available for inspection
- Product quality reviews and stability studies for every product
- Change control, deviations and CAPA documented and closed
- Complaints, recalls and not-of-standard-quality reports handled under written procedures
- Annual self-inspection against revised Schedule M
- Retention fee paid on time and changes reported promptly
Regovex offers periodic Schedule M audits and mock inspections, so your plant in Panipat, Haryana stays inspection-ready, not just license-ready.
How Regovex Handles Your Drug Manufacturing License in Panipat, Haryana
- Free GMP readiness check of your product plan, site and stage of construction
- License map: the forms you need, products needing CDSCO permission, and a realistic timeline
- Revised Schedule M gap analysis of layout, flows, HVAC, water and quality system
- Documentation: Site Master File, product documents, SOP index, validation and stability plans
- Technical staff verification before they are named in the application
- Application on the Online National Drugs Licensing System (ONDLS) or your state's own portal with fees, and query replies within 24–48 hours
- Inspection preparation: mock inspection, briefing and a written checklist
- Observation closure and grant, followed by retention fee and product addition tracking
Why Pharma Manufacturers in Panipat, Haryana Choose Regovex
- Manufacturing and licensing under one roof. We work as your drug license consultant for the plant and as your CDSCO registration consultant for products needing central permission.
- Revised Schedule M focus. Gap analyses and documentation built to the 2023 standard that now applies to every unit.
- State FDA approval experience with plant inspections, observation responses and joint inspections.
- Third-party and loan license expertise for brand owners and contract manufacturers.
- AYUSH manufacturing under Schedule T, as well as allopathic.
- Transparent pricing, with professional and government fees shown separately in writing.
- 99.8% approval rate across 100+ clients, rated 4.9/5 in verified client feedback.
Drug Manufacturing License Services in Panipat, Haryana and Nearby Areas
Regovex supports pharma manufacturing companies, new plant promoters, loan licensees and AYUSH manufacturers in Panipat, Haryana. Documents are prepared with your team digitally, applications are filed on the Online National Drugs Licensing System (ONDLS) or your state's own portal, and we provide on-site support for gap analyses and inspections where needed.
We also serve manufacturers in .
Other services in Panipat, Haryana:
- Drug License in Panipat, Haryana
- Wholesale Drug License in Panipat, Haryana
- Retail Pharmacy License in Panipat, Haryana
- CDSCO Registration in Panipat, Haryana
- Cosmetic Manufacturing License
What Our Clients Say
"Since the product category was relatively new and the guidelines were not very clearly defined, it required additional research and careful interpretation of the regulations. Devansh put in the effort to thoroughly study the requirements." — Parichit Dhawan, Director, Feorah Wellness & Cosmetics (Cosmetic and wellness regulatory approvals)
"I got my Drug Wholesale License through Regovex Consulting, and Devansh and his team provided complete end-to-end support, from premises selection to timely approval." — Bilal Ahmed Khan, Founder, Medwell Pharma
"Got my approval in committed time with complete transparency and zero hassle." — Baburam, Samarpaan Cloud Kitchen (FSSAI food license)
Step-by-step process
How our Panipat registration works
Assess your business model and Panipat regulatory classification.
Prepare and verify applicant documents and premises layout.
Submit application to the state/zonal authority covering Panipat and track queries.
Receive final license delivery with ongoing compliance alerts.
Documents required
Filing checklist for Panipat
- Identity and address proof of the applicant/directors
- Premises ownership or valid rental agreement in Panipat
- Layout plan and site dimensions of the facility
- Business constitution documents (COI/Partnership Deed)
- Affidavits and declarations as required by Panipat authority
Verified Support in Panipat
Whether you are located in the business center of Panipat or surrounding industrial corridors, our consultants manage state and zonal submissions directly.
Guaranteed Benefits
Drug Manufacturing License in India in Nearby Cities
Explore our fast-track regulatory consultancy and compliance assistance in nearby locations:
Other Compliance Services in Panipat
Complete statutory and license solutions provided by our regulatory consultants:
Find your question below or submit your inquiry for quick assistance.
Drug Manufacturing License Consultant in Panipat, Haryana: Regovex Consulting
Regovex Consulting helps pharma manufacturing companies, new plant promoters and brand owners get their drug manufacturing license in Panipat, Haryana and keep it. A drug manufacturing license is granted under the Drugs and Cosmetics Act, 1940 for a specific plant and a specific list of products: on Form 25 for most drugs, on Form 28 for Schedule C and C(1) drugs such as injectables and biologicals, and on Form 25-A or 28-A for loan licenses. In Panipat, Haryana, the license is granted by the State Drug Licensing Authority of your state after a document review and a pre-licensing inspection of the plant.
Pharma manufacturing in India now runs on revised Schedule M. The updated good manufacturing practices, notified in December 2023, have applied to every allopathic manufacturer since 1 January 2026. They require a Pharmaceutical Quality System, quality risk management, validated processes and equipment, data integrity, product quality reviews and stability studies. A new plant must meet them at its first inspection, and existing units face risk-based inspections. Regovex runs a revised Schedule M gap analysis of your layout, HVAC, water system and documentation before you build or apply, because changing a plant after inspection costs far more than designing it right.
Ready to proceed?
